Drug Therapy
US Congress 114th Congress
Heroin and Prescription Drug Abuse Prevention and Reduction Act [S.2562]
[Healthcare ]
[Public Health ]
[Mental Health ]
[Overdose Prevention ]
[Pharmaceuticals ]
[Insurance ]
[Labor, Jobs, Employment ]
[Funding ]
[Grants ]
[Medicare and Medicaid ]
[Consumer Protection ]
[Children and Youth ]
Heroin and Prescription Drug Abuse Prevention and Reduction Act This bill amends the Controlled Substances Act to revise requirements for and limitations on practitioners who dispense narcotic drugs for maintenance or detoxification treatment. The Department of Health and Human Services (HHS) must establish grant programs to: (1) encourage prescribing and purchase of opioid overdose reversal drugs (e.g., naloxone), and (2) develop prescribing guidelines for such drugs. (Opioids are drugs with effects similar to opium, such as heroin or certain pain
(continued...)
Sponsored by: Sen. Sherrod Brown
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 02/22/2016
Spread the world
Gettr US Congress 114th Congress
Adding Zika Virus to the FDA Priority Review Voucher Program Act [S.2512]
[Healthcare ]
[Public Health ]
[Pharmaceuticals ]
Adding Zika Virus to the FDA Priority Review Voucher Program Act (Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to add Zika virus disease to the list of tropical diseases under the priority review voucher program, which awards a voucher to the sponsor of a new drug or biological product that is approved to prevent or treat a tropical disease. (A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.) The bill makes a technical correction
(continued...)
Sponsored by: Sen. Robert Casey
Became Public Law No: 114-146. (txt | Pdf) on 04/19/2016
Spread the world
US Congress 114th Congress
Patient Safety Improvement Act of 2016 [S.2467]
[Healthcare ]
[Medicare and Medicaid ]
[Public Health ]
[Data Privacy ]
[Funding ]
[Grants ]
Patient Safety Improvement Act of 2016 This bill amends the Public Health Service Act to require the Centers for Disease Control and Prevention (CDC), in collaboration with the Agency for Healthcare Research and Quality (AHRQ) and stakeholders, to develop a framework to improve the consistency and reliability of hospital data on health care-associated infections. AHRQ must establish a pilot program to test collection and reporting of health care-associated infections data by additional health facilities. The Department of Health and Human Services
(continued...)
Sponsored by: Sen. Sheldon Whitehouse
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 01/27/2016
Spread the world
US Congress 114th Congress
Medicare and Medicaid Improvements and Adjustments Act of 2015 [S.2409]
[Healthcare ]
[Medicare and Medicaid ]
[Criminal Justice ]
[Public Health ]
[Pharmaceuticals ]
[Technology and Innovation ]
[Cybersecurity ]
[Law Enforcement ]
[Crime ]
Medicare and Medicaid Improvements and Adjustments Act of 2015 This bill amends titles XVIII (Medicare) and XIX (Medicaid) of the Social Security Act to modify payment rules and other provisions related to the Medicare and Medicaid programs. The bill includes off-campus outpatient department (OPD) services in Medicare's prospective payment system (in which predetermined amounts form the basis of payment) with respect to departments that are under development. The existing Medicare payment adjustment for cancer hospitals shall apply to off-campus
(continued...)
Sponsored by: Sen. Ron Wyden
Read Twice And Referred To The Committee On Finance. on 12/16/2015
Spread the world
US Congress 114th Congress
Co-Prescribing Saves Lives Act of 2016 [S.2256]
[Healthcare ]
[Overdose Prevention ]
[Pharmaceuticals ]
[Public Health ]
[Veterans ]
[Military ]
Co-Prescribing Saves Lives Act of 2016 (Sec. 2) This bill requires the Department of Health and Human Services to provide information to certain prescribers on best practices for prescribing naloxone for patients receiving chronic opioid therapy or being treated for opioid use disorders. (Naloxone is a prescription drug used to rapidly reverse an overdose of opioids, which are drugs with effects similar to opium, such as heroin and certain pain medications.) The information must be provided to prescribers in federally qualified health centers and
(continued...)
Sponsored by: Sen. Tim Kaine
Committee On Health, Education, Labor, And Pensions. Reported By Senator Alexander With An Amendment In The Nature Of A Substitute. Without Written Report. on 04/27/2016
Spread the world
US Congress 114th Congress
Improving Treatment for Pregnant and Postpartum Women Act of 2015 [S.2226]
[Healthcare ]
[Public Health ]
[Mental Health ]
[Children and Youth ]
[Human Services ]
[Overdose Prevention ]
Improving Treatment for Pregnant and Postpartum Women Act of 2015 This bill amends the Public Health Service Act to extend support for residential substance abuse treatment programs for pregnant and postpartum women through FY2020. The Center for Substance Abuse Treatment must carry out a pilot program to make grants to state substance abuse agencies to support services for pregnant and postpartum women who have a primary diagnosis of a substance use disorder.
Sponsored by: Sen. Susan Collins
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 11/03/2015
Spread the world
US Congress 114th Congress
End of Suffering Act of 2015 [S.2204]
[Healthcare ]
[Public Health ]
[Mental Health ]
[Pharmaceuticals ]
End of Suffering Act of 2015 This bill prohibits any federal or state law, regulation, or agency action from restricting the right of a mentally competent adult who is suffering from an advanced illness with intolerable pain or a terminal illness to receive pain relief treatment from a physician. A physician who treats such an individual is not subject to criminal or civil prosecution or professional disciplinary action if the physician obtains the written informed consent of the patient through a form that must be developed by the Department of
(continued...)
Sponsored by: Sen. Barbara Boxer
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 10/22/2015
Spread the world
US Congress 114th Congress
Medical Countermeasure Innovation Act of 2016 [S.2055]
[Healthcare ]
[Public Health ]
[Pharmaceuticals ]
[Science ]
Medical Countermeasure Innovation Act of 2016 (Sec. 2) This bill amends the Public Health Service Act to require the Department of Health and Human Services (HHS) to ensure the issuance of timely and accurate guidelines regarding the use of medical products for countering public health emergencies or material threats. HHS must report on funding for procurement of medical countermeasures when available funds are below a specified amount. (Sec. 3) The Biomedical Advanced Research and Development Authority's (BARDA's) contracting authority for procurement
(continued...)
Sponsored by: Sen. Robert Casey
Committee On Health, Education, Labor, And Pensions. Reported By Senator Alexander With An Amendment In The Nature Of A Substitute. Without Written Report. on 03/14/2016
Spread the world
US Congress 114th Congress
Promoting Life-Saving New Therapies for Neonates Act of 2015 [S.2041]
[Healthcare ]
[Pharmaceuticals ]
[Public Health ]
[Children and Youth ]
Promoting Life-Saving New Therapies for Neonates Act of 2015 This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to award the sponsor of a new drug or biological product for the treatment of newborns a neonatal drug exclusivity voucher upon approval of the medication. A neonatal drug exclusivity voucher is a transferable voucher for a one-year extension of all existing patents and marketing exclusivities for a brand name medication. For a sponsor to be eligible for a voucher, the new medication
(continued...)
Sponsored by: Sen. Robert Casey
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 09/16/2015
Spread the world
US Congress 114th Congress
Advancing Targeted Therapies for Rare Diseases Act of 2016 [S.2030]
[Healthcare ]
[Pharmaceuticals ]
[Science ]
[Public Health ]
Advancing Targeted Therapies for Rare Diseases Act of 2016 (Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to permit the Food and Drug Administration to allow the sponsor of a new drug or biological product for the treatment of a rare, serious condition to rely upon information submitted for an approved medication that uses the same technology. For a sponsor to be eligible to rely upon submitted information: (1) the sponsor must have developed, or have a right of reference to, the relied upon information; and (2) the new medication
(continued...)
Sponsored by: Sen. Elizabeth Warren
Committee On Health, Education, Labor, And Pensions. Reported By Senator Alexander With An Amendment In The Nature Of A Substitute. Without Written Report. on 04/05/2016
Spread the world
US Congress 114th Congress
Orphan Drug Fairness Act [S.1906]
[Healthcare ]
[Pharmaceuticals ]
Orphan Drug Fairness Act This bill amends the Patient Protection and Affordable Care Act (PPACA) to exclude sales of any drug or biological product approved by the Food and Drug Administration solely for rare diseases or conditions (orphan drug) from the calculation of the annual fee on manufacturers or importers with branded prescription drug sales exceeding $5 million. This Act is effective as if included in PPACA.
Sponsored by: Sen. Robert Menendez
Read Twice And Referred To The Committee On Finance. on 07/30/2015
Spread the world
US Congress 114th Congress
Mental Health Awareness and Improvement Act of 2015 [S.1893]
[Healthcare ]
[Mental Health ]
[Public Health ]
[Children and Youth ]
[Overdose Prevention ]
[Pharmaceuticals ]
[Senior Citizens ]
Mental Health Awareness and Improvement Act of 2015 (Sec. 2) This bill amends the Public Health Service Act to expand the focus of a youth interagency research, training, and technical assistance resource center from youth suicides to suicide at any age, particularly among groups at high risk for suicide. The center is reauthorized through FY2020. This bill revises and extends through FY2020 grant programs for: (1) the development of state or tribal youth suicide early intervention and prevention strategies, (2) enhancement of services for students
(continued...)
Sponsored by: Sen. Robert Casey
Referred To The Subcommittee On Health. on 01/08/2016
Spread the world
US Congress 114th Congress
Childhood Cancer STAR Act Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2015 [S.1883]
[Healthcare ]
[Public Health ]
[Science ]
[Children and Youth ]
[Funding ]
[Grants ]
[Pharmaceuticals ]
Childhood Cancer STAR Act Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2015 This bill amends the Public Health Service Act to permit the National Institutes of Health (NIH) to provide support to collect the medical specimens and information of children, adolescents, and young adults with cancer to improve the understanding of these cancers and of the effects of treatment. The national childhood cancer registry is reauthorized through FY2020 and revised to require the Centers for Disease Control and Prevention to award grants
(continued...)
Sponsored by: Sen. Robert Casey
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. (sponsor Introductory Remarks On Measure: Cr S6138) on 07/29/2015
Spread the world
US Congress 114th Congress
Advancing Hope Act of 2016 [S.1878]
[Healthcare ]
[Pharmaceuticals ]
[Public Health ]
[Children and Youth ]
Advancing Hope Act of 2016 This bill amends the Federal Food, Drug, and Cosmetic Act to expand the priority review voucher program for rare pediatric diseases to include treatments for sickle cell disease and pediatric cancers. The voucher program is extended by removing the provision terminating the program one year after the Food and Drug Administration's (FDA's) issuance of three rare pediatric disease vouchers. A voucher may not be issued for a rare pediatric disease product if a voucher was issued for the product as a tropical disease product.
(continued...)
Sponsored by: Sen. Robert Casey
Became Public Law No: 114-229. (txt | Pdf) on 09/30/2016
Spread the world
US Congress 114th Congress
PATH Act Promise for Antibiotics and Therapeutics for Health Act [S.185]
[Healthcare ]
[Pharmaceuticals ]
[Public Health ]
PATH Act Promise for Antibiotics and Therapeutics for Health Act Amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to establish a program to approve as a limited population antibacterial drug an antibacterial drug intended to treat a serious medical condition and to address an unmet medical need within an identifiable limited population. Requires the FDA's determination of the safety and effectiveness of these drugs to reflect the drug's benefit-risk profile in the intended limited population. Prohibits
(continued...)
Sponsored by: Sen. Richard Blumenthal
Committee On Health, Education, Labor, And Pensions. Reported By Senator Alexander With An Amendment In The Nature Of A Substitute. Without Written Report. on 04/18/2016
Spread the world
US Congress 114th Congress
Joint Formularies for Veterans Act of 2015 [S.1721]
[Veterans ]
[Healthcare ]
[Pharmaceuticals ]
[Mental Health ]
[Public Health ]
[Military ]
Joint Formularies for Veterans Act of 2015 This bill directs the Department of Defense (DOD) and the Department of Veterans Affairs (VA) to jointly establish: (1) a uniform formulary with respect to systemic pain and psychotropic drugs that are critical for the transition of an individual from receiving health care services furnished by DOD to health care services furnished by VA, and (2) a uniform formulary for DOD and VA that includes all appropriate systemic pain and psychotropic drugs. Nothing in this Act shall be construed to prohibit DOD and
(continued...)
Sponsored by: Sen. John McCain
Read Twice And Referred To The Committee On Veterans' Affairs. on 07/08/2015
Spread the world
US Congress 114th Congress
Clay Hunt SAV Act Clay Hunt Suicide Prevention for American Veterans Act [S.167]
[Healthcare ]
[Veterans ]
[Mental Health ]
[Student Loans ]
[Public Health ]
[Military ]
[Funding ]
[Grants ]
[Overdose Prevention ]
Clay Hunt SAV Act Clay Hunt Suicide Prevention for American Veterans Act Requires the Secretary of Veterans Affairs (VA) to arrange for an independent third party evaluation, to be conducted by September 30, 2018, and each fiscal year thereafter, of the VA's mental health care and suicide prevention programs. Directs the Secretary to survey the VA's websites and information resources to publish a website that serves as a centralized source to provide veterans with information regarding the VA's mental health care services. Requires the Secretary
(continued...)
Sponsored by: Sen. Robert Casey
Read Twice And Referred To The Committee On Veterans' Affairs. on 01/13/2015
Spread the world
US Congress 114th Congress
Jason Simcakoski Memorial Opioid Safety Act [S.1641]
[Healthcare ]
[Veterans ]
[Overdose Prevention ]
[Pharmaceuticals ]
[Public Health ]
[Mental Health ]
[Military ]
Jason Simcakoski Memorial Opioid Safety Act This bill directs the Department of Veterans Affairs (VA) and the Department of Defense (DOD) to jointly update the VA/DOD Clinical Practice Guideline for Management of Opioid Therapy for Chronic Pain, including guidelines regarding: prescribing opioids for outpatient treatment of chronic, non-cancer pain; contraindications for opioid therapy; treatment of patients with post-traumatic stress disorder, psychiatric disorders, or a history of substance abuse or addiction; case management for patients transitioning
(continued...)
Sponsored by: Sen. Dianne Feinstein
Read Twice And Referred To The Committee On Veterans' Affairs. (sponsor Introductory Remarks On Measure: Cr S4539) on 06/22/2015
Spread the world
US Congress 114th Congress
Cancer Drug Coverage Parity Act of 2015 [S.1566]
[Healthcare ]
[Pharmaceuticals ]
[Insurance ]
[Public Health ]
Cancer Drug Coverage Parity Act of 2015 This bill amends the Public Health Service Act to require a group or individual health plan that covers anticancer medications administered by a health care provider to provide no less favorable coverage for anticancer medications administered by a patient. A plan may apply to patient-administered anticancer medications only the cost-sharing and limitations that apply to anticancer medications administered by a health care provider. These requirements apply to medication approved by the Food and Drug Administration
(continued...)
Sponsored by: Sen. Susan Collins
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 06/11/2015
Spread the world
US Congress 114th Congress
Second Chance Reauthorization Act [S.1513]
[Crime ]
[Criminal Justice ]
[Funding ]
[Grants ]
[Public Safety ]
Second Chance Reauthorization Act Amends the Omnibus Crime Control and Safe Streets Act of 1968 to revise and expand requirements for the Department of Justice (DOJ) grant program for adult and juvenile offender state and local reentry demonstration projects, including for planning and implementation and for promotion of employment opportunities, and to extend the program through FY2020. Sets forth criteria and priority considerations for DOJ to use in awarding grants. Amends the Second Chance Act of 2007 to extend through FY2020 the authorization
(continued...)
Sponsored by: Sen. Cory Booker
Read Twice And Referred To The Committee On The Judiciary. on 06/04/2015